NTPC vs SUNPHARMA: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. NTPC shows a lower P/E and a higher dividend yield, while SUN PHARMACEUTICAL IND L shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
NTPC leads 3; SUNPHARMA leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | NTPC | SUNPHARMA |
|---|---|---|
| Sector | Power | Healthcare |
| Industry | Power Generation | Pharmaceuticals |
Price
| Metric | NTPC | SUNPHARMA |
|---|---|---|
| Live Price | ₹298 | ₹1,748 |
| Day Change | -1.52% | -0.57% |
| Volume | 87.52 L | 10.65 L |
| 52-Week High | ₹414.4 | ₹2,046.9 |
| 52-Week Low | ₹297.55 | ₹1,583.7 |
| Distance from 52W High | -28.09% | -14.6% |
Valuation
| Metric | NTPC | SUNPHARMA |
|---|---|---|
| Market Cap | ₹2.89 L Cr | ₹4.18 L Cr |
| P/E Ratio | 10.41x | 34.58x |
| P/B Ratio | 1.42x | 5x |
| EPS | ₹6.93 | ₹12.06 |
| Book Value | ₹217.76 | ₹349.6 |
| Dividend Yield | 3.02% | 0.92% |
Growth
| Metric | NTPC | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 8% | 12.8% |
| EPS Growth (TTM YoY) | -1.6% | 25.6% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | NTPC | SUNPHARMA |
|---|---|---|
| ROE | 13.25% | 13.72% |
| ROCE | 9.06% | 15.16% |
| Net Margin | 15.38% | 18.56% |
| Operating Margin | 19.94% | 26.44% |
| Debt to Equity | 1.09x | 0.05x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | NTPC | SUNPHARMA |
|---|---|---|
| Promoter Holding | 51.1% | 52.68%▼ 1.8 pp |
| FII Holding | 15.79%▼ 0.51 pp | 14.36%▼ 0.17 pp |
| DII Holding | 29.87%▲ 0.43 pp | 22.27%▲ 0.09 pp |
| Public Holding | 3.24%▲ 0.09 pp | 10.7%▲ 1.89 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NTPC and SUN PHARMACEUTICAL IND L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.